The latest evidence can be found in patient-centered oncology magazines:
Direct-to-consumer advertising of oncology medications typically focuses on the drugs’ benefits, as would be expected, but it does so in a manner that might lead some cancer patients to not appreciate equally the drugs’ potential side effects and risks.
